We are live on
!
Find out more
Legend Biotech
LEGN
LEGN
141 hedge funds and large institutions have $1.85B invested in Legend Biotech in 2022 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 68 increasing their positions, 32 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
113% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 32
50% more call options, than puts
Call options by funds: $19.3M | Put options by funds: $12.9M
24% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 21
1% more funds holding
Funds holding: 139 → 141 (+2)
0.27% more ownership
Funds ownership: 16.43% → 16.7% (+0.27%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
21% less capital invested
Capital invested by funds: $2.33B → $1.85B (-$481M)
Holders
141
Holders Change
+2
Holders Change %
+1.44%
% of All Funds
2.22%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
26
Increased
68
Reduced
32
Closed
21
Calls
$19.3M
Puts
$12.9M
Net Calls
+$6.4M
Net Calls Change
+$9.61M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$63.7M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$40.3M |
| 3 |
BlackRock
New York
|
+$25.3M |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$17.6M |
| 5 |
FFM
FengHe Fund Management
Singapore
|
+$17.3M |
